Home Data Calendar Blog

HARP

Tables

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Common Stock Value 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00NANANA0.00
Weighted Average Number Of Diluted Shares Outstanding NA33.0633.04NANA32.6432.51NANANANANANANANANANANANANANA
Weighted Average Number Of Shares Outstanding Basic NA33.0633.04NANA32.6432.51NANANANANANANANANANANANANANA
Weighted Average Number Of Share Outstanding Basic And Diluted NANANA32.88NA32.6432.5131.5825.2525.0824.9624.8324.6124.4624.2914.751.191.081.020.970.94
Earnings Per Share Basic -0.55-0.35-0.53NA-0.66-0.51-0.52NANANANANANANANANANANANANANA
Earnings Per Share Diluted -0.55-0.35-0.53NA-0.66-0.51-0.52NANANANANANANANANANANANANANA
Earnings Per Share Basic And Diluted NANANA-0.62-0.66-0.51-0.52-1.95-0.45-0.53-0.51-0.51-0.58-0.65-0.49-0.92-8.15-6.23-5.89-5.04-5.27

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Revenue From Contract With Customer Excluding Assessed Tax 4.0913.628.305.914.334.485.849.017.493.892.763.302.231.421.061.061.061.061.061.560.71
Revenues 4.0913.628.305.914.334.485.849.017.493.892.763.302.231.421.061.061.061.061.061.560.71
Operating Expenses 22.8025.5125.7126.2225.8721.1622.6170.7718.9917.4815.8716.4317.0418.0313.7115.2110.937.917.126.515.70
Research And Development Expense 18.9520.9820.6520.8220.6616.9718.2716.2215.0613.0611.9212.5212.719.539.979.388.725.976.155.534.79
General And Administrative Expense 3.854.535.065.405.204.194.334.603.924.433.943.914.338.493.735.832.211.940.970.980.91
Operating Income Loss -18.71-11.89-17.41-20.31-21.54-16.68-16.77-61.77-11.50-13.59-13.11-13.13-14.80-16.61-12.64-14.15-9.87-6.85-6.05-4.95-5.00
Allocated Share Based Compensation Expense 1.491.782.522.842.652.342.342.141.331.501.180.850.640.590.470.370.210.170.140.15NA
Profit Loss -18.42-11.64-17.35-20.32-21.55-16.68-16.76-61.72-11.36-13.31-12.69-12.55-14.27-15.91-11.82-13.58-9.73-6.76-5.99-4.88NA
Net Income Loss -18.42-11.64-17.35-20.32-21.55-16.68-16.76-61.72-11.36-13.31-12.69-12.55-14.27-15.91-11.82-13.58-9.73-6.76-5.99-4.88NA
Comprehensive Income Net Of Tax -18.39-11.61-17.32-20.36-21.60-16.68-16.75-61.74-11.48-13.42-12.92-12.12-14.31-15.93-11.73-13.55-9.73-6.76-5.99-4.88NA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Assets 73.7383.50108.95132.45155.45174.67196.18261.32171.59183.32197.12162.50176.60142.39157.02166.93102.58NANANA31.87
Liabilities 68.3366.5882.3191.0697.3897.70105.25158.94117.75122.58125.2279.2082.3835.1634.5433.3426.48NANANA18.97
Liabilities And Stockholders Equity 73.7383.50108.95132.45155.45174.67196.18261.32171.59183.32197.12162.50176.60142.39157.02166.93102.58NANANA31.87
Stockholders Equity 5.4016.9126.6441.3858.0776.9790.93102.3853.8460.7471.9183.2994.22107.23122.47133.59-53.48-43.98-37.50-31.67-26.94

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Assets Current 54.7369.1594.04116.94137.69156.19175.68234.28129.75157.72174.78128.70150.62122.99137.32140.6590.22NANANA29.65
Cash And Cash Equivalents At Carrying Value 51.6150.3768.5750.7444.6942.9977.4171.3321.1722.6534.7436.1788.7456.7652.0995.9389.4927.8615.5622.2029.42
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 52.2951.0469.2451.4145.3643.4677.8871.8021.6423.1235.2036.6389.2057.2352.5696.3989.9628.3215.5622.2029.42
Marketable Securities Current 1.5015.7321.5961.7390.41108.3993.60158.08104.86132.16136.8886.9359.34NANANANANANANANA
Prepaid Expense And Other Assets Current 1.613.053.884.482.604.804.664.873.722.923.165.602.541.763.442.080.73NANANA0.22
Available For Sale Securities Debt Securities 47.4661.1585.81107.42134.80150.71173.15234.40144.50159.35173.74136.45103.44103.22102.64101.89NANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Property Plant And Equipment Gross 15.7815.7815.5915.5115.4314.2914.2314.2314.1813.9513.7613.3913.3013.1813.386.814.01NANANA2.46
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment 8.547.867.346.796.195.635.094.544.003.462.932.421.911.411.611.311.01NANANA0.37
Property Plant And Equipment Net 7.247.928.258.729.258.669.149.6810.1910.4910.8310.9811.3811.7711.775.503.00NANANA2.09
Other Assets Noncurrent 0.910.810.870.810.860.700.750.811.120.890.870.760.530.520.470.603.58NANANA0.14
Available For Sale Debt Securities Amortized Cost Basis 47.4661.1785.86107.51134.85150.71173.15234.41144.50159.22173.50135.98103.40103.14102.53101.86NANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Liabilities Current 52.4354.0658.2258.5859.1455.3854.6998.1647.9245.2139.0523.8122.5116.6914.5111.9011.95NANANA6.92
Accounts Payable Current 4.712.642.794.192.671.602.002.641.571.781.591.542.593.904.523.414.36NANANA1.17
Other Accrued Liabilities Current 0.140.090.240.300.880.080.080.100.130.200.100.230.341.341.620.280.20NANANA0.10
Accrued Liabilities Current 14.3615.6317.1615.8117.3614.0416.3463.2013.8510.449.067.137.507.724.883.663.34NANANA1.49
Contract With Customer Liability Current 30.9433.9636.5036.8837.4638.1534.8230.8431.3031.6427.0913.8711.214.084.254.254.25NANANA4.25

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Operating Lease Liability Noncurrent 13.589.149.6310.0910.5410.9711.4011.8012.3112.6913.0613.3913.73NANANANANANANANA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Stockholders Equity 5.4016.9126.6441.3858.0776.9790.93102.3853.8460.7471.9183.2994.22107.23122.47133.59-53.48-43.98-37.50-31.67-26.94
Common Stock Value 0.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.000.00NANANA0.00
Additional Paid In Capital Common Stock 357.92351.04349.16346.58342.90340.21337.48332.19221.90217.33215.07213.53212.34211.04210.35209.749.11NANANA8.31
Retained Earnings Accumulated Deficit -352.52-334.10-322.46-305.11-284.79-263.24-246.56-229.79-168.07-156.71-143.41-130.72-118.16-103.89-87.99-76.17-62.59NANANA-35.23
Accumulated Other Comprehensive Income Loss Net Of Tax -0.00-0.03-0.06-0.09-0.05NA-0.00-0.020.000.130.240.470.04NANANANANANANANA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value NA1.782.522.84NA2.342.342.14NA1.501.180.85NA0.590.470.37NANANA0.15NA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Net Cash Provided By Used In Operating Activities -18.39-23.95-21.60-25.24-16.83-20.68-66.57-18.08-15.17-13.4937.55-17.5233.72-11.24-12.95-12.43-6.44-7.10-6.44-7.14NA
Net Cash Provided By Used In Investing Activities 14.255.6539.3830.4618.69-14.1269.69-39.9010.450.33-39.09-35.32-2.2715.81-31.20-51.65-0.16-0.19-0.22-0.09NA
Net Cash Provided By Used In Financing Activities 5.390.100.050.830.050.382.95108.143.241.070.100.270.530.100.3270.5168.2420.060.020.01NA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Net Cash Provided By Used In Operating Activities -18.39-23.95-21.60-25.24-16.83-20.68-66.57-18.08-15.17-13.4937.55-17.5233.72-11.24-12.95-12.43-6.44-7.10-6.44-7.14NA
Net Income Loss -18.42-11.64-17.35-20.32-21.55-16.68-16.76-61.72-11.36-13.31-12.69-12.55-14.27-15.91-11.82-13.58-9.73-6.76-5.99-4.88NA
Profit Loss -18.42-11.64-17.35-20.32-21.55-16.68-16.76-61.72-11.36-13.31-12.69-12.55-14.27-15.91-11.82-13.58-9.73-6.76-5.99-4.88NA
Depreciation Depletion And Amortization 0.680.530.550.600.560.530.550.550.540.530.510.500.50-0.200.300.300.200.160.150.14NA
Increase Decrease In Accounts Payable 2.10-0.18-0.820.950.57-0.46-0.641.07-0.410.220.06-1.09-1.060.18-0.10-0.772.560.020.48-0.51NA
Share Based Compensation 1.491.782.522.842.652.342.342.141.331.501.180.850.640.590.470.370.210.170.140.15NA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Net Cash Provided By Used In Investing Activities 14.255.6539.3830.4618.69-14.1269.69-39.9010.450.33-39.09-35.32-2.2715.81-31.20-51.65-0.16-0.19-0.22-0.09NA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Net Cash Provided By Used In Financing Activities 5.390.100.050.830.050.382.95108.143.241.070.100.270.530.100.3270.5168.2420.060.020.01NA

    2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31
Revenues 4.0913.628.305.914.334.485.849.017.493.892.763.302.231.421.061.061.061.061.061.560.71
Abb Vie Inc, Collaborative Arrangement NA8.208.305.904.304.505.204.405.403.202.202.90NA1.101.101.10NA1.40NA1.10NA
Revenue From Contract With Customer Excluding Assessed Tax 4.0913.628.305.914.334.485.849.017.493.892.763.302.231.421.061.061.061.061.061.560.71
Collaboration And License 4.0913.628.305.914.334.485.849.017.493.892.763.302.231.421.061.061.061.061.061.56NA
Collaboration And License, Abb Vie Development And Option Agreement 1.988.238.305.914.334.485.184.425.393.242.242.90NANANANANANANANANA
Collaboration And License, Abb Vie Restated Collaboration Agreement 2.115.39NANA0.000.000.664.582.100.660.520.390.501.421.061.06NANANANANA

Plots across concepts


IncomeStatement
Operating Income Loss
Expenses
Allocated Share Based Compensation Expense
Balance Sheet
Stockholders Equity
Assets
Property Plant And Equipment Net
Current Assets
Marketable Securities Current
NonCurrent Assets
Other Assets Noncurrent
PropertyPlantAndEquipmentNet
Property Plant And Equipment Net
Liabilities
Operating Lease Liability
Current Liabilities
Other Accrued Liabilities Current
Stockholders Equity
Retained Earnings Accumulated Deficit
CashFlow
Net Income Loss
NetCashProvidedByUsedInOperatingActivities
Net Income Loss
Shares
Weighted Average Number Of Share Outstanding Basic And Diluted
OperatingLeaseLiability
Operating Lease Liability Current
LesseeOperatingLeaseLiabilityPaymentsDue
Lessee Operating Lease Liability Payments Remainder Of Fiscal Year

Line plots across dimensions of each concept


TTM Greenblatt ROC
_
(None,)
T T M  Greenblatt  R O C_
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType
('harp:CollaborationAndLicense', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Research And Development Arrangement Contract To Perform For Others By Type
us-gaap:AllocatedShareBasedCompensationExpense
us-gaap:IncomeStatementLocation
(None,)
Allocated Share Based Compensation Expenseus-gaap: Income Statement Location
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:ShortTermInvestments')
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:CashEquivalents')
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:InvestmentType
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Investment Type
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:FinancialInstrument
(None,)
Available For Sale Securities Debt Securitiesus-gaap: Financial Instrument
us-gaap:AvailableForSaleSecuritiesDebtSecurities
us-gaap:ExtinguishmentOfDebt, us-gaap:FinancialInstrument
('harp:ShortTermMarketableSecurities', None)
Available For Sale Securities Debt Securitiesus-gaap: Extinguishment Of Debt, us-gaap: Financial Instrument
us-gaap:PropertyPlantAndEquipmentGross
us-gaap:PropertyPlantAndEquipmentByType
(None,)
Property Plant And Equipment Grossus-gaap: Property Plant And Equipment By Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:ShortTermInvestments')
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument, us-gaap:InvestmentType
(None, 'us-gaap:CashEquivalents')
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument, us-gaap: Investment Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:InvestmentType
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Investment Type
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:FinancialInstrument
(None,)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Financial Instrument
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
us-gaap:ExtinguishmentOfDebt, us-gaap:FinancialInstrument
('harp:ShortTermMarketableSecurities', None)
Available For Sale Debt Securities Amortized Cost Basisus-gaap: Extinguishment Of Debt, us-gaap: Financial Instrument
us-gaap:StockholdersEquity
us-gaap:StatementEquityComponents
(None,)
Stockholders Equityus-gaap: Statement Equity Components
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:ProductOrService, us-gaap:ResearchAndDevelopmentArrangementContractToPerformForOthersByType
('harp:CollaborationAndLicense', None)
Revenue From Contract With Customer Excluding Assessed Taxus-gaap: Product Or Service, us-gaap: Research And Development Arrangement Contract To Perform For Others By Type